Results 171 to 180 of about 201,919 (214)
Some of the next articles are maybe not open access.

Pharmacotherapy for obesity

Current Atherosclerosis Reports, 2007
Obesity is a chronic metabolic disorder that affects one third of American adults. Modest weight losses of just 5% to 10% of body weight, which are achievable with lifestyle modification and pharmacotherapy, can lead to remarkable improvements in many obesity-associated co-morbidities, including dyslipidemia, hypertension, and type 2 diabetes.
Lisa M, Neff, Louis J, Aronne
openaire   +2 more sources

Pharmacotherapy of insomnia

Expert Opinion on Pharmacotherapy, 2012
Insomnia is one of the most prevalent sleep disorders in developed countries, being surpassed only by chronic sleep deprivation. Patients with insomnia tend to have an altered quality of life, impaired daytime functioning and an increased risk of work accidents and motor vehicle crashes.
Octavian C, Ioachimescu, Ali A, El-Solh
openaire   +2 more sources

Pharmacotherapy in Alcoholism

Alcoholism Treatment Quarterly, 1994
This review categorizes five main uses of pharmacologic agents in the treatment of alcoholism: reversing the active pharmacologic effects of alcohol; controlling withdrawal symptoms; blocking the desire for alcohol use; treating psychiatric symptoms induced by alcohol and other drugs; and treating independent, but concurrent, psychopathologic ...
openaire   +2 more sources

Pharmacotherapy of Osteoarthritis

American Journal of Physical Medicine & Rehabilitation, 2006
ABSTRACT Stitik TP, Altschuler E, Foye PM: Pharmacotherapy of osteoarthritis. Am J Phys Med Rehabil 2006;85(Suppl):S15–S28.
Todd P, Stitik   +2 more
openaire   +2 more sources

Pharmacotherapy in pregnancy

Therapeutische Umschau, 1999
Zwischen 1958 und 1961 wurden rund 10000 Kinder mit schweren Gliedmaßendefekten geboren, deren Mütter das Schlafmittel Thalidomid eingenommen hatten. Seit dieser Katastrophe herrscht bei pharmazeutischer Industrie, Ärzten und Patientinnen berechtigte Vorsicht, häufig jedoch auch irrationale Panik im Hinblick auf den Einsatz von Arzneimitteln in der ...
openaire   +2 more sources

Pharmacotherapy of Dyslipidemia

Cardiovascular Drugs and Therapy, 2001
Reducing elevated levels of low-density-lipoprotein cholesterol (LDL-C) significantly reduces the incidence of coronary heart disease (CHD) events and mortality in hypercholesterolemic patients. CHD risk reduction is proportional to LDL-C reduction. Despite this knowledge, many physicians are not applying existing treatment guidelines to the extent ...
openaire   +2 more sources

Pharmacotherapy of insomnia

Expert Opinion on Pharmacotherapy, 2008
Insomnia is the most common sleep disorder in the industrialized world. A variety of precipitating events have been identified, but when it becomes a persistent problem, maladaptive patterns become established, thereby, perpetuating the sleep disturbance.
Abid, Bhat   +2 more
openaire   +2 more sources

The pharmacotherapy of pulpitis

Oral Surgery, Oral Medicine, Oral Pathology, 1962
Abstract We have discussed the possibility of applying pharmacotherapy in pulpitis by means of a combination of highly potent corticoids, antibiotics, and local anesthetics. This preparation was used in severe to very severe cases, some of which presented exposure of the pulp, accompanying periodontitis, and neuralgiform pains.
A, SCHROEDER, H, TRIADAN
openaire   +2 more sources

Pharmacotherapy of Asthma

American Journal of Health-System Pharmacy, 1976
The pharmacological management of asthma is reviewed. Drugs discussed include: (1) sympathomimetic amines, (2) theophylline, (3) cromolyn sodium and (4) corticosteroids. Aspects of treatment discussed include: initial evaluation, therapy for acute symptoms, and chronic asthma.
M, Weinberger, L, Hendeles
openaire   +3 more sources

Pharmacotherapy of cryptococcosis

Expert Opinion on Pharmacotherapy, 2009
Cryptococcus neoformans is an opportunistic fungal pathogen that causes central nervous system and pulmonary disease among immunocompromised patients. Recent studies highlight the high incidence of cryptococcosis among patients in certain resource-poor areas, where there is also a high incidence of AIDS.
Michele, Ritter, David L, Goldman
openaire   +2 more sources

Home - About - Disclaimer - Privacy